Currency in USD
Earnings estimate | Current qtr. (Jun 2023) | Next qtr. (Sep 2023) | Current year (2023) | Next year (2024) |
---|
No. of analysts | 1 | 1 | 2 | 2 |
Avg. Estimate | 0.84 | 1.05 | 3.64 | 3.92 |
Low estimate | 0.84 | 1.05 | 3.62 | 3.88 |
High estimate | 0.84 | 1.05 | 3.67 | 3.97 |
Year ago EPS | 0.87 | 1.1 | 3.44 | 3.64 |
Revenue estimate | Current qtr. (Jun 2023) | Next qtr. (Sep 2023) | Current year (2023) | Next year (2024) |
---|
No. of analysts | 2 | 2 | 4 | 4 |
Avg. Estimate | 8.47B | 9.51B | 36B | 38.46B |
Low estimate | 8.31B | 9.45B | 35.62B | 37.83B |
High estimate | 8.62B | 9.57B | 36.51B | 39.29B |
Year ago sales | 8.7B | 8.24B | 36.1B | 36B |
Sales growth (year/est) | -2.70% | 15.30% | -0.30% | 6.90% |
Earnings history | 29/06/2022 | 29/09/2022 | 30/12/2022 | 30/03/2023 |
---|
Est. EPS | 0.73 | 0.96 | 0.5 | 0.82 |
Actual EPS | 0.87 | 1.1 | 0.6 | 0.9 |
Difference | 0.14 | 0.14 | 0.1 | 0.08 |
Surprise % | 19.20% | 14.60% | 20.00% | 9.80% |
EPS trend | Current qtr. (Jun 2023) | Next qtr. (Sep 2023) | Current year (2023) | Next year (2024) |
---|
Current estimate | 0.84 | 1.05 | 3.64 | 3.92 |
7 days ago | 0.84 | 1.05 | 3.64 | 3.92 |
30 days ago | 0.84 | 1.05 | 3.7 | 3.95 |
60 days ago | 0.9 | 1.06 | 3.66 | 3.94 |
90 days ago | 0.93 | 1.09 | 3.7 | 3.97 |
EPS revisions | Current qtr. (Jun 2023) | Next qtr. (Sep 2023) | Current year (2023) | Next year (2024) |
---|
Up last 7 days | N/A | N/A | 1 | 1 |
Up last 30 days | N/A | N/A | 1 | 1 |
Down last 7 days | N/A | N/A | N/A | N/A |
Down last 30 days | N/A | N/A | N/A | N/A |
Growth estimates | GSK | Industry | Sector(s) | S&P 500 |
---|
Current qtr. | -3.40% | N/A | N/A | N/A |
Next qtr. | -4.50% | N/A | N/A | N/A |
Current year | 5.80% | N/A | N/A | N/A |
Next year | 7.70% | N/A | N/A | N/A |
Next 5 years (per annum) | 5.00% | N/A | N/A | N/A |
Past 5 years (per annum) | -2.63% | N/A | N/A | N/A |